Huron Consulting Group (NASDAQ:HURN) Updates FY 2025 Earnings Guidance

Huron Consulting Group (NASDAQ:HURN) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 6.800-7.600 for the period, compared to the consensus earnings per share estimate of 7.160. The company issued revenue guidance of $1.6 billion-$1.7 billion, compared to the consensus revenue estimate of $1.6 billion.

Huron Consulting Group Price Performance

Huron Consulting Group stock traded up $0.14 on Wednesday, reaching $142.52. The company’s stock had a trading volume of 4,882 shares, compared to its average volume of 141,252. Huron Consulting Group has a twelve month low of $84.26 and a twelve month high of $153.85. The company has a market cap of $2.55 billion, a price-to-earnings ratio of 30.99 and a beta of 0.37. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.61 and a current ratio of 1.61. The business’s fifty day moving average price is $140.33 and its 200 day moving average price is $126.94.

Huron Consulting Group (NASDAQ:HURN) last released its quarterly earnings data on Tuesday, February 25th. The business services provider reported $1.90 earnings per share for the quarter, topping the consensus estimate of $1.52 by $0.38. The business had revenue of $399.31 million for the quarter, compared to analyst estimates of $380.62 million. Huron Consulting Group had a net margin of 5.80% and a return on equity of 21.51%. Equities analysts expect that Huron Consulting Group will post 6.1 earnings per share for the current fiscal year.

Analyst Ratings Changes

Several research analysts recently commented on HURN shares. Truist Financial increased their target price on shares of Huron Consulting Group from $165.00 to $180.00 and gave the stock a “buy” rating in a report on Tuesday, March 4th. Barrington Research reaffirmed an “outperform” rating and set a $167.00 price target on shares of Huron Consulting Group in a research report on Thursday, March 27th. William Blair reissued an “outperform” rating on shares of Huron Consulting Group in a research note on Wednesday, March 26th. Benchmark reissued a “buy” rating and issued a $165.00 price objective on shares of Huron Consulting Group in a research report on Wednesday, March 26th. Finally, Wedbush raised their target price on shares of Huron Consulting Group from $150.00 to $165.00 and gave the company an “outperform” rating in a research note on Wednesday, March 26th. Six research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock currently has an average rating of “Buy” and an average target price of $169.25.

Insider Activity at Huron Consulting Group

In other news, Director John Mccartney sold 500 shares of the business’s stock in a transaction dated Monday, March 3rd. The shares were sold at an average price of $151.13, for a total value of $75,565.00. Following the completion of the sale, the director now owns 55,688 shares of the company’s stock, valued at approximately $8,416,127.44. The trade was a 0.89 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director H Eugene Lockhart sold 1,042 shares of Huron Consulting Group stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $125.15, for a total transaction of $130,406.30. Following the completion of the sale, the director now owns 24,672 shares of the company’s stock, valued at $3,087,700.80. This trade represents a 4.05 % decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 78,781 shares of company stock worth $11,484,452. Insiders own 2.02% of the company’s stock.

About Huron Consulting Group

Huron Consulting Group Inc, a professional services firm, provides consultancy services in the United States and internationally. It operates through three segments: Healthcare, Education, and Commercial. The Healthcare segment provides financial and operational performance improvement consulting services; digital offerings, spanning technology and analytic-related services; software products; organizational transformation services; revenue cycle managed and outsourcing services; financial and capital advisory consulting services; and strategy and innovation consulting services to national and regional health systems, academic and community health systems, federal health system, public, children’s and critical access hospitals, physician practices and medical groups, payors, and long-term care or post-acute providers.